GE HealthCare Technologies Inc. Share Price
Equities
GEHC
US36266G1076
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.46 USD | +3.56% |
|
+6.84% | +9.31% |
| 12-03 | University of Rochester Medical Center and GE Healthcare Form Seven-Year Care Alliance to Build Advanced Capabilities Across System | CI |
| 12-03 | GE Healthcare and Mayo Clinic Unveils Gemini-Rt | CI |
| Capitalization | 38.93B 33.46B 31.35B 29.22B 53.97B 3,504B 58.7B 367B 142B 1,655B 146B 143B 6,050B | P/E ratio 2025 * |
18.7x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 43.99B 37.81B 35.42B 33.02B 60.98B 3,959B 66.33B 414B 160B 1,870B 165B 162B 6,837B | EV / Sales 2025 * |
2.15x | EV / Sales 2026 * | 1.98x |
| Free-Float |
96.76% | Yield 2025 * |
0.17% | Yield 2026 * | 0.18% |
Last Transcript: GE HealthCare Technologies Inc.
| 1 day | +3.56% | ||
| 1 week | +6.84% | ||
| Current month | +6.84% | ||
| 1 month | +16.99% | ||
| 3 months | +12.85% | ||
| 6 months | +19.32% | ||
| Current year | +9.31% |
| 1 week | 79.35 | 85.56 | |
| 1 month | 70.04 | 85.56 | |
| Current year | 57.65 | 94.8 | |
| 1 year | 57.65 | 94.8 | |
| 3 years | 53 | 94.8 | |
| 5 years | 53 | 94.8 | |
| 10 years | 53 | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Arduini
CEO | Chief Executive Officer | 60 | 13/12/2022 |
James Saccaro
DFI | Director of Finance/CFO | 52 | 31/05/2023 |
Taha Kass-Hout
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Arduini
BRD | Director/Board Member | 60 | 13/12/2022 |
Catherine Lesjak
BRD | Director/Board Member | 66 | 13/12/2022 |
Rodney Hochman
BRD | Director/Board Member | 69 | 02/01/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.56% | +6.84% | +5.19% | - | 38.93B | ||
| -0.43% | -3.06% | +8.20% | +2.62% | 215B | ||
| +1.18% | +0.32% | +4.53% | +114.71% | 204B | ||
| -0.39% | -0.23% | -1.68% | -15.65% | 160B | ||
| -0.20% | -4.00% | +8.27% | +113.72% | 145B | ||
| -0.06% | +2.18% | -16.88% | -11.97% | 56.48B | ||
| +0.48% | -0.55% | +20.49% | +18.75% | 50.02B | ||
| -1.91% | -5.22% | +3.49% | -5.36% | 41.18B | ||
| +2.00% | +0.28% | +6.27% | +15.47% | 37.39B | ||
| +1.19% | -0.79% | -22.99% | -35.36% | 34.62B | ||
| Average | +0.54% | -0.37% | +1.49% | +21.88% | 98.21B | |
| Weighted average by Cap. | +0.26% | -1.09% | +3.53% | +39.54% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.49B 17.62B 16.5B 15.38B 28.41B 1,845B 30.9B 193B 74.54B 871B 76.92B 75.28B 3,185B | 21.43B 18.42B 17.25B 16.08B 29.7B 1,928B 32.31B 202B 77.92B 911B 80.41B 78.7B 3,330B |
| Net income | 2.1B 1.81B 1.69B 1.58B 2.92B 189B 3.17B 19.81B 7.65B 89.41B 7.89B 7.73B 327B | 2.17B 1.87B 1.75B 1.63B 3.01B 195B 3.27B 20.45B 7.9B 92.28B 8.15B 7.97B 337B |
| Net Debt | 5.06B 4.35B 4.07B 3.8B 7.02B 455B 7.63B 47.66B 18.4B 215B 18.99B 18.59B 786B | 3.39B 2.91B 2.73B 2.54B 4.7B 305B 5.11B 31.93B 12.33B 144B 12.72B 12.45B 527B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 85.46 $ | +3.56% | 4,439,631 |
| 04/12/25 | 82.52 $ | -1.28% | 3,321,365 |
| 03/12/25 | 83.59 $ | +4.20% | 5,253,942 |
| 02/12/25 | 80.22 $ | +1.24% | 2,367,919 |
| 01/12/25 | 79.24 $ | -0.94% | 2,541,151 |
Delayed Quote Nasdaq, December 05, 2025 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GEHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















